6 completed, 3 active not recruiting, 3 unknown, 2 recruiting. 18 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Completed 6, Active not recruiting 3, Unknown 3, Recruiting 2, Withdrawn 2, Not yet recruiting 1, Terminated 1 |
Follow Latent Infection: new trials by email Literature Review of Latent Infection trials Research Report on Latent Infection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparative Trial Between Ainuovirine(ANV)/Lamivudine(3TC)/Tenofovir(TDF) and Efavirenz(EFV)/Lamivudine/Tenofovir Regimens Ainuovirine, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, Tenofovir, Lamivudine and Efavirenz Disoproxil Fumarate Tablets - HIV, Art Therapy | Phase 4 | Not yet recruiting | Shanghai Public Health Clinical Center | 60 | 2026-06-01 | 2026-06-08 |
| Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease Rifampicin plus Isoniazid, Rifapentine plus Isoniazid, Rifampicin alone - Latent Tuberculosis, Kidney Failure | Phase 4 | Unknown | Miguel Santín | 225 | 2024-04-20 | 2024-03-15 |
| Clinical Trial of Mica Mycobacterium Vaccae for Injection - Latent Tuberculosis Infection | Phase 4 | Active not recruiting | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 6800 | 2023-04-19 | 2024-06-25 |
| Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein Recombinant Mycobacterium tuberculosis fusion protein for injection, TB-PPD was injected - Latent Tuberculosis Infection | Phase 4 | Completed | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 7500 | 2023-04-17 | 2024-09-19 |
| Latent Infection Freshmen Tracking for Tuberculosis tuberculosis preventive treatment - Latent Tuberculosis Infection (LTBI), Tuberculosis (TB) | Phase 4 | Recruiting | Affiliated Hospital of Nantong University | 3000 | 2022-08-15 | 2026-09-10 |
| One-month Latent Tuberculosis Treatment for Renal Transplant Candidates 1 month Rifapentine, Isoniazid and Vitamin B6 - Latent Tuberculosis, End Stage Renal Disease | Phase 4 | Active not recruiting | Rutgers, The State University of New Jersey | 25 | 2022-07-01 | 2026-01-21 |
| The Safety, Completion Rate and Prevention Effect by Rifamycin-containing Regimens for Latent Tuberculosis Infection in Patients With Kidney Transplantation: a Prospective Intervention Pilot Study Rifamycin-containing regimen, Rifamycin-free regimen - Pulmonology | Phase 4 | Recruiting | National Taiwan University Hospital | 500 | 2022-01-01 | 2022-10-20 |
| Impact of LTBI Treatment on Glucose Tolerance and Chronic Inflammation Rifampicin 300 Mg Oral Capsule, Isoniazid 300 Mg ORAL TABLET - Latent Tuberculosis, Diabetes Mellitus, Type 2 | Phase 4 | Completed | Herlev and Gentofte Hospital | 32 | 2021-04-15 | 2023-05-16 |
| BCG Re-vaccination for Primary Tuberculosis Prophylaxis in the Prison Population BCG - Latent Tuberculosis | Phase 4 | Withdrawn | Federal University of Mato Grosso | 2020-08-17 | 2023-10-19 | |
| Efficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL) Isoniazid 300 mg Oral Tablet, Rifampin 600 mg Oral Tablet - Diabetes Mellitus, Tuberculin (Skin Test) Positive | Phase 4 | Completed | Instituto Nacional de Salud Publica, Mexico | 396 | 2019-02-28 | 2019-04-26 |
| Latent Tuberculosis in Type 2 Diabetes Rifapentine and Isoniazid for 3 months, Isoniazid (INH) daily for 9 months - Latent Tuberculosis Infection | Phase 4 | Active not recruiting | Taichung Veterans General Hospital | 552 | 2018-04-18 | 2025-03-13 |
| Evaluation of Diabetes Control and Effect on Transmission and Development of Tuberculosis Isoniazid 300Mg Tab, Isoniazid 300 MG - Latent Tuberculosis, Diabetes Mellitus | Phase 4 | Withdrawn | Instituto Nacional de Salud Publica, Mexico | 2012-09-01 | 2018-04-17 | |
| QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study. Preventive treatment with Isoniazid., Preventive treatment with Isoniazid - Latent Tuberculosis Infection | Phase 4 | Completed | Hospital Universitari de Bellvitge | 871 | 2010-07-01 | 2016-05-27 |
| Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL) Isoniazid - Human Immunodeficiency Virus (HIV), Tuberculosis (TB) | Phase 4 | Unknown | Instituto Nacional de Salud Publica, Mexico | 100 | 2010-05-01 | 2013-06-12 |
| Treatment of Latent Tuberculosis Infection With Isoniazid Isoniazid, isoniazid - Tuberculosis | Phase 4 | Completed | Instituto Nacional de Salud Publica, Mexico | 200 | 2007-02-01 | 2010-05-26 |
| Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver Disease Tuberculin skin test, Quantiferon-TB Gold assay - Chronic Liver Disease, Liver Transplantation | Phase 4 | Completed | University Health Network, Toronto | 300 | 2006-10-01 | 2008-04-16 |
| Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care Workers tuberculin for skin test - Tuberculosis, Latent Tuberculosis | Phase 4 | Unknown | Taichung Veterans General Hospital | 300 | 2004-01-01 | 2006-04-05 |
| Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection I ( isoniazid), II (isoniazid + rifampin ) - Tuberculosis | Phase 4 | Terminated | Hospital Virgen de la Luz | 228 | 1996-03-01 | 2008-12-31 |
Latent Tuberculosis (18) · Tuberculosis (9) · Diabetes Mellitus (3) · Acquired Immunodeficiency Syndrome (1) · Diabetes Mellitus, Type 2 (1) · Kidney Failure, Chronic (1) · Renal Insufficiency (1)
Actinomycetales Infections (18) · Bacterial Infections (18) · Bacterial Infections and Mycoses (18) · Gram-Positive Bacterial Infections (18) · Infections (18) · Mycobacterium Infections (18) · Tuberculosis (9) · Endocrine System Diseases (4) · Glucose Metabolism Disorders (4) · Metabolic Diseases (4) · Nutritional and Metabolic Diseases (4) · Urogenital Diseases (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Isoniazid (10) · Rifampin (4) · rifapentine (3) · Injections (2) · Tablets (2) · Tuberculin (2) · Isonicotinic Acids (1) · Lamivudine (1) · Skin Tests (1) · Tenofovir (1) · Vitamin B 6 (1)
Instituto Nacional de Salud Publica, Mexico (4) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (2) · Taichung Veterans General Hospital (2) · Affiliated Hospital of Nantong University (1) · Federal University of Mato Grosso (1) · Herlev and Gentofte Hospital (1) · Hospital Universitari de Bellvitge (1) · Hospital Virgen de la Luz (1) · Miguel Santín (1) · National Taiwan University Hospital (1) · Rutgers, The State University of New Jersey (1) · Shanghai Public Health Clinical Center (1) · University Health Network, Toronto (1)
China (4) · Mexico (3) · Spain (2) · Taiwan (2) · Brazil (1) · Canada (1) · Denmark (1) · United States (1)
Yi Mo, Master (2) · Alfredo Ponce-de-Leon, MD (1) · Chin-Chung Shu (1) · Deepali Kumar, MD (1) · Eduardo Sada-Diaz, MD (1) · Garcia-Garcia Lourdes, Doctor (1) · I-Te Lee (1) · Jose Sifuentes-Osornio, MD (1) · Julio HR Croda, PhD (1) · Lourdes Garcia-Garcia, MD (1) · Maria Paloma Geijo Martinez, MD (1)
PMID 25359354, PMID 17504682, PMID 29020191, PMID 36269714, PMID 38918780, PMID 39350021, PMID 40560769
2009 (1)